Fetal asphyctic preconditioning modulates the acute cytokine response thereby protecting against perinatal asphyxia in neonatal rats

Journal of Neuroinflammation

Volumn 10, Issue 1, 2013, Pages

  Vlassaks, Evi ^a,b   Strackx, Eveline ^a,b   Vles, Johan S H ^a   Nikiforou, Maria ^a,b   Martinez Martinez, Pilar ^b   Kramer, Boris W ^a   Gavilanes, Antonio W D ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Asphyxia; Cytokines; Inflammation; Perinatal; Preconditioning

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PHOSPHOPROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH; CONTROLLED STUDY; CYTOKINE RESPONSE; DEVELOPMENTAL STAGE; DOWN REGULATION; EMBRYO; FEMALE; FETAL ASPHYCTIC PRECONDITIONING; FETUS; FETUS HYPOXIA; GENE EXPRESSION; HEMISPHERE; ISCHEMIC PRECONDITIONING; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEWBORN; NONHUMAN; PERINATAL ASPHYXIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUP (RODENT); RAT; UTERINE BLOOD VESSEL; ANIMAL; ASPHYXIA; BIOSYNTHESIS; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; METHODOLOGY; PREGNANCY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; ASPHYXIA; CYTOKINES; FEMALE; ISCHEMIC PRECONDITIONING; MALE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84872819127     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-14     Document Type: Article

References (43)

1. Low JA: Determining the contribution of asphyxia to brain damage in the neonate. J Obstet Gynaecol Res 2004, 30:276-286.
2. Berger R, Garnier Y: Pathophysiology of perinatal brain damage. Brain Res Brain Res Rev 1999, 30:107-134.
3. Thoresen M: Hypothermia after perinatal asphyxia: selection for treatment and cooling protocol. J Pediatr 2011, 158:45-49.
4. Strackx E, Van den Hove DL, Prickaerts J, Zimmermann L, Steinbusch HW, Blanco CE, Gavilanes AW, Vles JS: Fetal asphyctic preconditioning protects against perinatal asphyxia-induced behavioral consequences in adulthood. Behav Brain Res 2010, 208:351-343.
5. Strackx E, Zoer B, Van den Hove D, Steinbusch H, Steinbusch H, Blanco C, Vles JS, Villamor E, Gavilanes AW: Brain apoptosis and carotid artery reactivity in fetal asphyctic preconditioning. Front Biosci (Schol Ed) 2010, 2:781-790.
6. Maslinska D, Laure-Kamionowska M, Kaliszek A, Makarewicz D: Proinflammatory cytokines in injured rat brain following perinatal asphyxia. Folia Neuropathol 2002, 40:177-182.
7. Ashdown H, Joita S, Luheshi GN, Boksa P: Acute brain cytokine responses after global birth hypoxia in the rat. J Neurosci Res 2008, 86:3401-3409.
8. Denes A, Thornton P, Rothwell NJ, Allan SM: Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun 2010, 24:708-723.
9. Silveira RC, Procianoy RS: Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr 2003, 143:625-629.
10. Okazaki K, Nishida A, Kato M, Kozawa K, Uga N, Kimura H: Elevation of cytokine concentrations in asphyxiated neonates. Biol Neonate 2006, 89:183-189.
11. Hagberg H, Gilland E, Bona E, Hanson LA, Hahin-Zoric M, Blennow M, Holst M, McRae A, Soder O: Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996, 40:603-609.
12. Szaflarski J, Burtrum D, Silverstein FS: Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke 1995, 26:1093-1100.
13. Shin JA, Park EM, Choi JS, Seo SM, Kang JL, Lee KE, Cho S: Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex. J Neuroimmunol 2009, 217:14-19.
14. Pradillo JM, Fernandez-Lopez D, Garcia-Yebenes I, Sobrado M, Hurtado O, Moro MA, Lizasoain I: Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J Neurochem 2009, 109:287-294.
15. Feng Z, Davis DP, Sasik R, Patel HH, Drummond JC, Patel PM: Pathway and gene ontology based analysis of gene expression in a rat model of cerebral ischemic tolerance. Brain Res 2007, 1177:103-123.
16. Yin W, Signore AP, Iwai M, Cao G, Gao Y, Johnnides MJ, Hickey RW, Chen J: Preconditioning suppresses inflammation in neonatal hypoxic ischemia via Akt activation. Stroke 2007, 38:1017-1024.
17. Strackx E, Van den Hove DL, Prickaerts J, Zimmermann L, Steinbusch HW, Blanco CE, Gavilanes AW, Vles JS: Fetal asphyctic preconditioning protects against perinatal asphyxia-induced behavioral consequences in adulthood. Behav Brain Res 2010, 208:343-351.
18. Strackx E, Zoer B, Van den Hove D, Steinbusch H, Blanco C, Vles JS, Villamor E, Gavilanes AW: Brain apoptosis and carotid artery reactivity in fetal asphyctic preconditioning. Front Biosci (Schol Ed) 2010, 2:781-790.
19. Soldan SS: Alvarez Retuerto AI, Sicotte NL, Voskuhl RR: Dysregulation of IL-10 and IL-12p40 in secondary progressive multiple sclerosis. J Neuroimmunol 2004, 146:209-215.
20. Satriotomo I, Bowen KK, Vemuganti R: JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia. J Neurochem 2006, 98:1353-1368.
21. Aly H, Khashaba MT, El-Ayouty M, El-Sayed O, Hasanein BM: IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev 2006, 28:178-182.
22. Vannucci RC, Vannucci SJ: A model of perinatal hypoxic-ischemic brain damage. Ann N Y Acad Sci 1997, 835:234-249.
23. Tyzio R, Cossart R, Khalilov I, Minlebaev M, Hubner CA, Represa A, Ben-Ari Y, Khazipov R: Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery. Science 2006, 314:1788-1792.
24. Chao CC, Hu S, Ehrlich L, Peterson PK: Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 1995, 9:355-365.
25. Haqqani AS, Nesic M, Preston E, Baumann E, Kelly J, Stanimirovic D: Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS. FASEB J 2005, 19:1809-1821.
26. Bona E, Andersson AL, Blomgren K, Gilland E, Puka-Sundvall M, Gustafson K, Hagberg H: Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr Res 1999, 45:500-509.
27. Brochu ME, Girard S, Lavoie K, Sebire G: Developmental regulation of the neuroinflammatory responses to LPS and/or hypoxia-ischemia between preterm and term neonates: An experimental study. J Neuroinflammation 2011, 8:55.
28. Kremlev SG, Roberts RL, Palmer C: Minocycline modulates chemokine receptors but not interleukin-10 mRNA expression in hypoxic-ischemic neonatal rat brain. J Neurosci Res 2007, 85:2450-2459.
29. Park KW, Lee HG, Jin BK, Lee YB: Interleukin-10 endogenously expressed in microglia prevents lipopolysaccharide-induced neurodegeneration in the rat cerebral cortex in vivo. Exp Mol Med 2007, 39:812-819.
30. Sharma S, Yang B, Xi X, Grotta JC, Aronowski J, Savitz SI: IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res 2011, 1373:189-194.
31. Martin-Ancel A, Garcia-Alix A, Pascual-Salcedo D, Cabanas F, Valcarce M, Quero J: Interleukin-6 in the cerebrospinal fluid after perinatal asphyxia is related to early and late neurological manifestations. Pediatrics 1997, 100:789-794.
32. Gadient RA, Otten UH: Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog Neurobiol 1997, 52:379-390.
33. Suzuki S, Tanaka K, Suzuki N: Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab 2009, 29:464-479.
34. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM: The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 2001, 15:43-58.
35. Yamashita T, Sawamoto K, Suzuki S, Suzuki N, Adachi K, Kawase T, Mihara M, Ohsugi Y, Abe K, Okano H: Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J Neurochem 2005, 94:459-468.
36. Yektaei-Karin E, Moshfegh A, Lundahl J, Berggren V, Hansson LO, Marchini G: The stress of birth enhances in vitro spontaneous and IL-8-induced neutrophil chemotaxis in the human newborn. Pediatr Allergy Immunol 2007, 18:643-651.
37. Munck A, Guyre PM, Holbrook NJ: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984, 5:25-44.
38. Wang L, Zhang W, Zhao Y: The study of maternal and fetal plasma catecholamines levels during pregnancy and delivery. J Perinat Med 1999, 27:195-198.
39. Gulmezoglu AM, Mahomed K, Hofmeyr GJ, Nikodem VC, Kramer T: Fetal and maternal catecholamine levels at delivery. J Perinat Med 1996, 24:687-691.
40. Martin D, Chinookoswong N, Miller G: The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol 1994, 130:362-367.
41. Sun Y, Calvert JW, Zhang JH: Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 2005, 36:1672-1678.
42. O'Shea JJ, Gadina M, Schreiber RD: Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002,109(Suppl):S121-131.
43. Suzuki S, Tanaka K, Nogawa S, Dembo T, Kosakai A, Fukuuchi Y: Phosphorylation of signal transducer and activator of transcription-3 (Stat3) after focal cerebral ischemia in rats. Exp Neurol 2001, 170:63-71.